Goldman Sachs’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.86M | Sell |
1,459,839
-1,001,105
| -41% | -$5.08M | ﹤0.01% | 3392 |
|
|
2025
Q4 | $10.5M | Buy |
2,460,944
+2,013,191
| +450% | +$7.65M | ﹤0.01% | 3053 |
|
|
2025
Q3 | $1.43M | Buy |
447,753
+433,075
| +2,951% | +$975K | ﹤0.01% | 4762 |
|
|
2025
Q2 | $33.3K | Sell |
14,678
-47,041
| -76% | -$75.8K | ﹤0.01% | 5951 |
|
|
2025
Q1 | $39.2K | Buy |
+61,719
| New | +$47.9K | ﹤0.01% | 5906 |
|
|
2024
Q4 | – | Sell |
-12,000
| Closed | -$14.2K | – | 6066 |
|
|
2024
Q3 | $14.2K | Sell |
12,000
-97,302
| -89% | -$124K | ﹤0.01% | 5688 |
|
|
2024
Q2 | $133K | Sell |
109,302
-184,592
| -63% | -$367K | ﹤0.01% | 5361 |
|
|
2024
Q1 | $641K | Buy |
+293,894
| New | +$542K | ﹤0.01% | 4616 |
|
|
2023
Q3 | – | Sell |
-10,217
| Closed | -$17.6K | – | 5592 |
|
|
2023
Q2 | $17.6K | Sell |
10,217
-3,180
| -24% | -$5.28K | ﹤0.01% | 5559 |
|
|
2023
Q1 | $20.2K | Sell |
13,397
-90,527
| -87% | -$205K | ﹤0.01% | 5668 |
|
|
2022
Q4 | $166K | Sell |
103,924
-29,769
| -22% | -$44K | ﹤0.01% | 5361 |
|
|
2022
Q3 | $194K | Sell |
133,693
-53,849
| -29% | -$82.9K | ﹤0.01% | 5499 |
|
|
2022
Q2 | $343K | Sell |
187,542
-571,047
| -75% | -$1.09M | ﹤0.01% | 5335 |
|
|
2022
Q1 | $2.03M | Buy |
758,589
+121,643
| +19% | +$467K | ﹤0.01% | 4249 |
|
|
2021
Q4 | $2.76M | Sell |
636,946
-472,119
| -43% | -$2.77M | ﹤0.01% | 3972 |
|
|
2021
Q3 | $5.64M | Buy |
1,109,065
+157,048
| +16% | +$841K | ﹤0.01% | 3251 |
|
|
2021
Q2 | $6.03M | Buy |
952,017
+742,915
| +355% | +$5.78M | ﹤0.01% | 3171 |
|
|
2021
Q1 | $1.62M | Sell |
209,102
-18,347
| -8% | -$145K | ﹤0.01% | 4191 |
|
|
2020
Q4 | $1.49M | Sell |
227,449
-52,374
| -19% | -$374K | ﹤0.01% | 3934 |
|
|
2020
Q3 | $1.86M | Buy |
279,823
+1,978
| +0.7% | +$14.7K | ﹤0.01% | 3624 |
|
|
2020
Q2 | $2.31M | Buy |
277,845
+139,797
| +101% | +$1.3M | ﹤0.01% | 3357 |
|
|
2020
Q1 | $1.06M | Sell |
138,048
-262,407
| -66% | -$1.83M | ﹤0.01% | 3714 |
|
|
2019
Q4 | $3.33M | Buy |
400,455
+11,725
| +3% | +$79.1K | ﹤0.01% | 3264 |
|
|
2019
Q3 | $2.87M | Sell |
388,730
-17,627
| -4% | -$174K | ﹤0.01% | 3284 |
|
|
2019
Q2 | $4.56M | Buy |
406,357
+208,982
| +106% | +$2.19M | ﹤0.01% | 2912 |
|
|
2019
Q1 | $2.12M | Sell |
197,375
-300,717
| -60% | -$4.45M | ﹤0.01% | 3605 |
|
|
2018
Q4 | $7.52M | Buy |
498,092
+42,039
| +9% | +$624K | ﹤0.01% | 2548 |
|
|
2018
Q3 | $8.44M | Sell |
456,053
-65,055
| -12% | -$1.48M | ﹤0.01% | 2586 |
|
|
2018
Q2 | $11.9M | Buy |
521,108
+102,216
| +24% | +$2.61M | ﹤0.01% | 2265 |
|
|
2018
Q1 | $11.9M | Sell |
418,892
-38,727
| -8% | -$1.11M | ﹤0.01% | 2207 |
|
|
2017
Q4 | $9.66M | Buy |
457,619
+132,454
| +41% | +$2.75M | ﹤0.01% | 2472 |
|
|
2017
Q3 | $5.91M | Buy |
325,165
+197,389
| +154% | +$3.08M | ﹤0.01% | 2994 |
|
|
2017
Q2 | $1.98M | Buy |
127,776
+116,794
| +1,064% | +$1.76M | ﹤0.01% | 3850 |
|
|
2017
Q1 | $190K | Buy |
+10,982
| New | +$145K | ﹤0.01% | 5754 |
|
|
2016
Q1 | – | Sell |
-15,278
| Closed | -$319K | – | 7108 |
|
|
2015
Q4 | $319K | Buy |
+15,278
| New | +$242K | ﹤0.01% | 5298 |
|
Other funds holding CTMX
KCM
PA
VA
VCM
